iNtRON Biotechnology, Inc. (048530.KQ) KOE
2,715.00
-5(-0.18%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
2,715.00
-5(-0.18%)
Currency In KRW
Address
137, Sagimakgol-ro
Seongnam-si,
Korea (the Republic of)
Phone
82 3 1739 5678
Website
Sector
Healthcare
Industry
Biotechnology
Employees
76
First IPO Date
January 26, 2011
| Name | Title | Pay | Year Born |
| Seong-Jun Yoon | Chief Executive Officer & President | 0 | 1969 |
| Kyung Won Yoon | Chief Executive Officer & Vice President - Planning & Management | 0 | N/A |
| Sang-Hyun Kang | Chief Technology Officer & Vice President - R&D Department | 0 | 1968 |
iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.